Registry for headache and vertigo conditions in China
Official title: China Headache and Vertigo Registry Study
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT04939922 · Data updated 2026-11-12
This study is collecting information from people of all ages who have headaches or vertigo to see how different treatments work and how these conditions relate to other health issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 4 Years to 99 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | June 12, 2017 |
| Main results expected | December 12, 2050 |
| Study ends | December 12, 2050 |
| Registry record updated | July 25, 2025 |
| Trial ID | NCT04939922 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 4 to 99 years diagnosed with primary or secondary headache disorders according to ICHD-3 criteria.
✕Probably not a fit
Patients who are unable to complete headache diaries or who cannot commit to long-term follow-up may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The China Headache Registry Study collects data from patients aged 4 to 99 years who suffer from various headache disorders, including migraines and tension-type headaches, as well as vertigo and chronic pain conditions. The study aims to investigate biomarkers, imaging features, genetic characteristics, and treatment outcomes related to these conditions. Participants will be followed long-term to assess the effectiveness of treatments and the relationship of headaches with other diseases. The study adheres to Good Clinical Practice (GCP) guidelines to ensure data integrity and participant safety.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of headache and vertigo disorders, ultimately enhancing patient care.
How similar studies have gone: While similar observational studies have been conducted, this specific registry approach focusing on a comprehensive range of headache and vertigo conditions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures. * Male or female participants ages 4 to 99 years. * Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches. * Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine). Exclusion Criteria: * Patients who were unable to complete scales such as headache diary. * Patients denied or unable to be admitted for long-term follow-up.
Where it's running
-
Kaiming Liu
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Kaiming Liu, Doctor — headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University
- Study coordinator: Kaiming Liu, Doctor
- Email: 2314411@zju.edu.cn
- Phone: +8615068862055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
International Headache Registry
This study is collecting information from people aged 4 to 99 who have headaches or related conditions to see how these issues affect their health and treatment over time.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
China Headache Disorders Registry (CHAIRS) for People with Migraine and Other Primary Headaches
This project will collect clinical, imaging, biomarker, genetic, and treatment outcome data from people aged 12 and older with primary headache disorders, including migraine and medication‑overuse headache, to see if patterns predict outcomes and guide care.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Home-based VR neurofeedback for adolescents with migraine
This program tests whether a home-based virtual reality system guided by a wearable EEG headband can help adolescents (ages 10–16) who have migraine.
-
Using virtual reality to teach relaxation techniques for kids with headaches
This study is testing if virtual reality can help kids with chronic headaches learn relaxation techniques to feel better and have fewer headaches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.